Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
30.04.2014 23:34:21

Hologic Q2 Loss Narrows; Lifts FY14 Outlook - Quick Facts

(RTTNews) - Hologic Inc. (HOLX) reported second-quarter net loss of $16.8 billion or $0.06 per share, narrower than $51.1 million or $0.19 per share last year.

Excluding items, adjusted earnings for the quarter were $103.11 million or $0.347per share, compared with $93.85 million or $0.35 per share a year ago. On average, 21 analysts polled by Thomson Reuters estimated earnings of $0.33 per share for the quarter. Analysts' estimates typically exclude special items.

Revenue for the quarter rose to $625.01 million, compared with $612.66 million in the prior year, while nineteen analysts had a consensus revenue estimate of $609.25 million for the quarter.

For the third quarter, Hologic expects adjusted earnings of $0.33 to $0.34 per share and revenue of $615 million to $625 million. Analysts expect earnings of $0.34 per share on revenue of $616.75 million.

For the full year 2014, Hologic now estimates adjusted earnings of $1.37 to 1.40 per share, up from its prior guidance of $1.34 to $1.38 per share. Analysts now expect earnings of $1.37 per share.

The company raised its revenue to a range of $2.46 billion to $2.49 billion from its prior range of $2.43 billion to $2.48 billion. Analysts expect revenue of $2.46 billion.

Analysen zu Hologic IncShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Hologic IncShs 75,00 0,00% Hologic IncShs